AQUA BIO TECHNOLOGY ASA: KEY INFORMATION RELATING TO THE SUBSEQUENT OFFERING
Reference is made to the announcement by Aqua Bio Technology ASA on 30 January 2024 concerning, among other things, a private placement with total gross proceeds of approximately NOK 12.46 million and a contemplated subsequent offering (the "Subsequent Offering").
|
Date on which the terms of the Subsequent Offering was announced: |
29 January 2024 |
|
Last day including right: |
30 January 2024 |
|
First day excluding right: |
31 January 2024 |
|
Record date: |
1 February 2024 |
|
Resolution date: |
30 January 2024 |
|
Maximum number of new shares: |
1,000,000 |
|
Subscription price: |
NOK 5 |
|
Shall the rights be listed |
No |
The formal resolution related to the Subsequent Offering will be made by the board of directors at a later time, and further information will be given in due course.
This information is published in accordance with the requirements of the Continuing Obligations.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.
Attachments
Subscribe to our company announcements
Keep up to date with our company announcements by subscribing.
Visit our pressroom and see more company announcements from us.
Our pressroom